A Phase I-II Study of Dietary Methionine Restriction and Temodar (Temozolomide) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme.

Trial Profile

A Phase I-II Study of Dietary Methionine Restriction and Temodar (Temozolomide) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 12 Jan 2012

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Jan 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 18 Feb 2009 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
    • 27 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top